What Makes RWE “Decision‑Grade” Evidence?

Not all real‑world evidence is created equal. Decision‑grade RWE meets the standards required for regulatory, payer, and clinical decision‑making

Key Characteristics

• Transparency: Clear documentation of data sources, methods, and assumptions

• Reproducibility: Analyses that can be replicated and validated independently

• Fit‑for‑Purpose Design: Methods tailored to the specific decision context

• Data Quality: Reliable, complete, and well‑curated datasets

• Robust Methods: Appropriate statistical techniques that address confounding and bias

• Clinical Relevance: Outcomes that matter to patients, clinicians, and payers

• Timeliness: Evidence generated quickly enough to inform real‑world decisions

Why It Matters

Decision‑grade RWE influences coverage, pricing, regulatory submissions, and clinical guidelines; it bridges the gap between controlled trials and real‑world practice

STEMfluence Perspective: Decision‑grade RWE is the future of evidence; it empowers stakeholders to make informed choices grounded in real‑world impact

To Spark Engagement:

·       Review a real‑world study you’ve encountered recently

·       Evaluate it using the following criteria: transparency, reproducibility, fit‑for‑purpose design, data quality, and clinical relevance

·       Identify one strength and one improvement needed for it to be considered decision‑grade